Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Surgery. 2010 May 14;148(2):364–370. doi: 10.1016/j.surg.2010.03.020

Figure 6.

Figure 6

Expression of CXCL5 mRNA in human umbilical vein vascular endothelial cells (HUVEC) treated with epidermal growth factor (EGF). The effect of EGF stimulation is abrogated by the pharmacologic EGFR tyrosine kinase inhibitors ZD1839 and AG1478. *Control vs. EGF stimulated p <0.01, † Baseline vs EGF stimulated p<0.01, ‡ZD vs EGF stimulated p <0.05, § AG vs EGF stimulated p <0.01